Replies to post #173 on ViroPharma Incorporated (VPHM)

[surf1944]

10:30AM ViroPharma announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (VPHM) 18.11 +0.06 : Co announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze in adults and adolescents with hereditary angioedema for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks. The approval also includes a self administration option for appropriately trained patients included in the Summary of Product Characteristics. HAE is a rare, debilitating and potentially life-threatening genetic disorder that affects at least 10,000 people in Europe.